Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Helsicore is a Finnish health technology company specializing in cardiovascular diagnostics and remote cardiac monitoring. The company developed a proprietary long-term ECG monitoring solution designed to detect arrhythmias, such as atrial fibrillation, which are often asymptomatic but significantly increase the risk of stroke. In May 2021, Helsicore was acquired by Zenicor Medical Systems, a leading Swedish medtech company, to enhance its diagnostic capabilities and market presence in Finland. Their technology integrates handheld ECG devices with cloud-based analysis software, providing healthcare professionals with efficient tools for early diagnosis and treatment planning. The acquisition allows for the integration of Helsicore's advanced algorithms into Zenicor's established clinical workflows. This synergy aims to improve patient outcomes through more accessible and accurate cardiac screening.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Helsicore.